US 7776827
Method of using substance P analogs for treatment amelioration of myelodysplastic syndrome
granted A61KA61K38/046A61P
Quick answer
US patent 7776827 (Method of using substance P analogs for treatment amelioration of myelodysplastic syndrome) held by ImmuneRegen Biosciences, Inc. expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ImmuneRegen Biosciences, Inc.
- Grant date
- Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K38/046, A61P, A61P7/06